What's with the Afterpay (ASX:APT) share price fall today?

The Afterpay Ltd (ASX: APT) share price is falling today, but with no news out from the company we take a look at other potential catalysts.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Afterpay Ltd (ASX: APT) share price is falling in trade today, currently down 3.3% at $148.38. This is despite the recent buy now, pay later (BNPL) excitement in other shares including Zip Co Ltd (ASX: Z1P), Fatfish Group Ltd (ASX: FFG), and IOUpay Ltd (ASX: IOU).

With no news from the company today, we look at what other forces might be at play.

A male ASX investor wearing glasses and a beanie and denim shirt puts his hand to his chin wondering whether to buy ASX shares

Image source: Getty Images

Catalysts for today's Afterpay share price selling

Could recent run-ups in BNPL competitors stem from an interest in finding the next big player? Particularly in cases like Fatfish and IOUpay, as they target new developing markets for the sector in Southeast Asia. The potential returns from investing at an early stage might have Afterpay shareholders taking profit and reallocating to these opportunities.

Alternatively, the case could be made that the tech sector is looking a bit frothy. Technology shares have outperformed through COVID-19 and the global market rebound.

Many investors found solace in companies with limited exposure to physical forms of business – in addition to the large role technology had in handling the events of the pandemic. However, some may perceive evaluations as stretched at this point, even when accounting for growth.

This perception of overvalued in many tech shares, including Afterpay, might lead investors to turn to value investing. That means blue-chip shares that look undervalued based on their earnings, often reflected in the price-to-earnings (P/E) ratio.

Is the growth engine still chugging along?

In a short timeframe of nearly 4 years, Afterpay has managed to grow like wildflowers. Merchants, customers, revenue – all the metrics have been humming along like a fine-tuned engine. For instance, revenue has rocketed from $22.906 million in 2017 to $476.555 million in 2020.

However, 2021 is a world away from 2017. Indeed, Afterpay now has countless contenders all wanting a piece of the BNPL pie. This might have investors nervous considering the company still hasn't turned a profit. The question weighing on the minds of some is, how much profit will be in it, given the saturation of competitors?

Afyterpay's recent sales in the United States indicate strong sales are still occurring for the company. The announcement posted on 2 December 2020 highlighted the company exceeding $2 billion of global sales in a single month. Furthermore, the US made up $1 billion of these sales, increasing 186% from the prior year.

The growth story will be clarified on 25 February, when the company is slated to release its half-year results for FY21.

Mitchell Lawler owns shares of AFTERPAY T FPO. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of ZIPCOLTD FPO. The Motley Fool Australia owns shares of AFTERPAY T FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy hump day session for the ASX.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

Scientists working in the laboratory and examining results.
Opinions

3 reasons to buy CSL shares today

The ASX biotech company has great growth potential this year.

Read more »

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Share Fallers

Why Brightstar, EQ Resources, Novonix, and Pro Medicus shares are falling today

These shares are under pressure on hump day. But why?

Read more »

A happy family of four on holidays stand on a jetty and cheer.
Broker Notes

Down 40% in 2026, should you buy the big dip in Life360 shares?

A leading analyst offers his outlook for Life360 shares.

Read more »

Buy and sell on yellow paper with pins on them and several share price lines.
Broker Notes

Sell alert! Why this expert is calling time on Nuix and Brainchip shares

A leading analyst forecasts more pain to come for Brainchip and Nuix shares. But why?

Read more »

Ecstatic woman looking at her phone outside with her fist pumped.
Share Gainers

Why EOS, Humm, New Hope, and Sims shares are storming higher today

These shares are having a good session on hump day. But why?

Read more »

a man lies on his back on grass with his eyes shut and a contented look on his face as though he is dreaming
Broker Notes

With global populations ageing, are ResMed shares a good buy today?

A leading expert delivers his verdict on the outlook for ResMed shares.

Read more »